Maryland Senate Bill SB189

Maryland 2022 Regular Session

• Introduced: 1/12/22
• Refer: 1/12/22

Caption

Controlled Substances - Schedules

Impact

The bill proposes significant changes to state law regarding substance classification, impacting how various drugs are regulated in Maryland. By updating the controlled substance schedules, the legislation is expected to help law enforcement agencies and healthcare providers better manage and address the issues related to substance abuse and addiction. This could lead to more effective preventative measures and treatments being implemented in response to substance use disorders.

Summary

Senate Bill 189 aims to amend the current Maryland Controlled Dangerous Substances Act by updating the lists of substances classified as controlled dangerous substances. The bill seeks to clarify the definitions and categories of drugs and substances included in Schedule I, Schedule II, and other relevant schedules. The revisions are intended to reflect the modern understanding of various substances and their potential for abuse, thus improving public health and safety.

Contention

While the bill is primarily designed to enhance public health measures and law enforcement's ability to tackle drug-related issues, there may be points of contention among different stakeholders. Concerns could arise regarding the potential for overregulation and the implications for patients needing specific medications. Discussions may also occur around the balance between controlling substances for public safety and ensuring access to necessary medical treatments.